X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7983) 7983
Book Review (1629) 1629
Publication (239) 239
Newsletter (221) 221
Book Chapter (97) 97
Magazine Article (51) 51
Newspaper Article (19) 19
Conference Proceeding (13) 13
Book / eBook (9) 9
Government Document (5) 5
Reference (4) 4
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6582) 6582
index medicus (6423) 6423
female (3350) 3350
hypercalcemia (3281) 3281
male (3103) 3103
hypercalcemia - etiology (2785) 2785
middle aged (2262) 2262
hypercalcemia - drug therapy (1837) 1837
adult (1788) 1788
aged (1524) 1524
abridged index medicus (1413) 1413
calcium - blood (1318) 1318
hypercalcemia - therapy (859) 859
animals (819) 819
hypercalcemia - diagnosis (787) 787
hypercalcemia - complications (778) 778
medicine, general & internal (772) 772
parathyroid hormone - blood (770) 770
diphosphonates - therapeutic use (754) 754
calcium (731) 731
endocrinology & metabolism (728) 728
hypercalcemia - chemically induced (711) 711
hyperparathyroidism (653) 653
oncology (643) 643
parathyroid hormone (622) 622
hypercalcemia - blood (583) 583
neoplasms - complications (564) 564
vitamin d (560) 560
urology & nephrology (546) 546
cancer (541) 541
calcium - metabolism (532) 532
diagnosis, differential (502) 502
treatment outcome (476) 476
surgery (446) 446
care and treatment (437) 437
adolescent (429) 429
bone neoplasms - secondary (423) 423
primary hyperparathyroidism (414) 414
child (400) 400
parathyroidectomy (395) 395
hyperparathyroidism - complications (394) 394
pediatrics (375) 375
diagnosis (369) 369
aged, 80 and over (367) 367
calcitonin - therapeutic use (364) 364
pamidronate (359) 359
calcium - urine (356) 356
medicine & public health (350) 350
hypercalcaemia (349) 349
parathyroid-hormone (335) 335
bisphosphonates (332) 332
risk factors (331) 331
hypercalcemia - physiopathology (321) 321
research (319) 319
malignancy (318) 318
drug therapy (316) 316
time factors (311) 311
osteoporosis (309) 309
hypercalcemia - metabolism (308) 308
renal dialysis (308) 308
retrospective studies (299) 299
therapy (296) 296
infant (284) 284
prognosis (281) 281
parathyroid neoplasms - complications (280) 280
management (278) 278
disease (276) 276
secondary hyperparathyroidism (273) 273
parathyroid hormone-related protein (267) 267
hyperparathyroidism - diagnosis (266) 266
hormone-related protein (248) 248
health aspects (247) 247
follow-up studies (241) 241
phosphates - blood (239) 239
rats (237) 237
bone (235) 235
kidney failure, chronic - complications (232) 232
infant, newborn (230) 230
parathyroid neoplasms - surgery (229) 229
transplantation (225) 225
patients (223) 223
bone neoplasms - drug therapy (221) 221
phosphorus - blood (221) 221
diphosphonates - administration & dosage (220) 220
child, preschool (217) 217
hematology (216) 216
tumors (216) 216
multiple myeloma - complications (214) 214
mice (213) 213
hyperparathyroidism - surgery (212) 212
humoral hypercalcemia (208) 208
kidney failure, chronic - therapy (208) 208
metabolism (207) 207
sarcoidosis (204) 204
hyperparathyroidism - etiology (202) 202
neoplasm metastasis (200) 200
bone density conservation agents - therapeutic use (197) 197
case report (195) 195
carcinoma (191) 191
sarcoidosis - complications (191) 191
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7148) 7148
French (346) 346
German (299) 299
Japanese (188) 188
Spanish (84) 84
Italian (65) 65
Danish (45) 45
Polish (44) 44
Dutch (24) 24
Russian (19) 19
Portuguese (18) 18
Korean (16) 16
Czech (15) 15
Hungarian (14) 14
Norwegian (13) 13
Swedish (9) 9
Finnish (8) 8
Chinese (7) 7
Hebrew (5) 5
Romanian (4) 4
Turkish (4) 4
Croatian (3) 3
Lithuanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 1013 - 1017
The RCC ‐ SELECT study showed the correlation between single nucleotide polymorphisms ( SNP ) in STAT 3 gene and survival in metastatic renal cell carcinoma (... 
overall survival | renal cell carcinoma | prognostic factors | interferon‐α | The Era of molecular targeted therapy | Interferon-α | Overall survival | Renal cell carcinoma | Prognostic factors | interferon-α | SURVIVAL | STAT3 POLYMORPHISM | FOLLOW-UP | SORAFENIB | PHASE-III TRIAL | RADICAL NEPHRECTOMY | HYPERCALCEMIA | INVASION | ONCOLOGY | SUNITINIB | interferon-alpha | JAPANESE PATIENTS | Kidney Neoplasms - genetics | Prognosis | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Case-Control Studies | Neoplasm Metastasis | Aged, 80 and over | Adult | Female | Carcinoma, Renal Cell - drug therapy | STAT3 Transcription Factor - genetics | Carcinoma, Renal Cell - pathology | Interferon-alpha - therapeutic use | Survival Rate | Treatment Outcome | Interferon-alpha - administration & dosage | Polymorphism, Single Nucleotide - genetics | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | Cohort Studies | Thrombocytopenia | Demography | Cell survival | Disease | Cytokines | Research funding | Stat3 protein | Histology | Single-nucleotide polymorphism | Metastasis | Multivariate analysis | Patients | Lymph nodes | Metastases | Hypercalcemia | Studies | Medical prognosis | Kidney cancer | Growth patterns | Interferon | Clear cell-type renal cell carcinoma | Index Medicus | Original
Journal Article
JAMA, ISSN 0098-7484, 02/2012, Volume 307, Issue 7, pp. 674 - 684
Journal Article
Journal Article
Nutrition, ISSN 0899-9007, 07/2019, Volume 63-64, pp. 120 - 125
The presence of obesity may confound cholecalciferol dosing in vitamin D–deficient patients owing to potentially decreased bioavailability. The aim of this... 
Obesity | Critical illness | Vitamin D | Calcium | Trauma | Cholecalciferol | ACUTE HYPOCALCEMIA | INITIATION | INJURY | LEVEL | VITAMIN-D DEFICIENCY | CARE | SUPPLEMENTATION | NUTRITION & DIETETICS | ASSOCIATION | Calcifediol | Care and treatment | Alfacalcidol | Hypercalcemia | Therapy | Nutrition | Laboratories | Bioavailability | Injuries | 25-Hydroxyvitamin D
Journal Article
Lung Cancer, ISSN 0169-5002, 2007, Volume 57, Issue 2, pp. 229 - 232
Journal Article
American Journal of Emergency Medicine, ISSN 0735-6757, 06/2018, Volume 36, Issue 6, pp. 1053 - 1056
Journal Article
The Journal for Nurse Practitioners, ISSN 1555-4155, 07/2018, Volume 14, Issue 7, pp. 567 - 568
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.nurpra.2018.03.016 
ONCOLOGIC EMERGENCIES | DIAGNOSIS | NURSING | Hypercalcemia | Diuretics | Drug therapy | Hydration | Vitamin D | Ligands | Kidney diseases | Patients | Drug dosages | Cancer
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 06/2016, Volume 36, Issue 6, pp. e54 - e57
Peginterferon alfa‐2a ( PEG ‐ IFN alfa‐2a) is commonly used to treat hepatitis C virus infection and is also being used increasingly to treat... 
hypercalcemia | sarcoidosis | polycythemia vera | peginterferon alfa‐2a | Hypercalcemia | Polycythemia vera | Peginterferon alfa-2a | Sarcoidosis | peginterferon alfa-2a | Care and treatment | Interferon | Hepatitis C | Polycythemia | Viral antigens
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0185446 - e0185446
Small animal studies have demonstrated significant high-dose recombinant parathyroid hormone1-34 (rPTH1-34) effects on intercalary allograft healing. Towards a... 
DEFECTS | ABALOPARATIDE | RECONSTRUCTION | MULTIDISCIPLINARY SCIENCES | PARATHYROID-HORMONE 1-34 | BONE REGENERATION | FRACTURES | GRAFT | POSTMENOPAUSAL WOMEN | UNION | AMPUTATION | Bony Callus - drug effects | Teriparatide - pharmacology | Teriparatide - therapeutic use | Teriparatide - administration & dosage | Fluorescence | Femur - transplantation | Bony Callus - pathology | Femur - physiopathology | Allografts - drug effects | Cone-Beam Computed Tomography | Dose-Response Relationship, Drug | Animals | Postoperative Care | Bony Callus - diagnostic imaging | Biomechanical Phenomena - drug effects | Dogs | Femur - surgery | Minerals - metabolism | Wound Healing - drug effects | Disease Models, Animal | Hypercalcemia | Care and treatment | Research | Diagnosis | Homografts | Bone grafts | Therapy | Femur | Callus | Intravenous administration | Transplants & implants | Calcium | Osteotomy | Apposition | Osteoporosis | Bone histomorphometry | Calcium (blood) | Biomedical materials | Allografts | Surgery | Biocompatibility | Safety | Bone (cortical) | Drug dosages | Parathyroid | Biomedical engineering | Recombinant | Rust | Bone healing | Unions | Biomechanics | Studies | Side effects | Bone cancer | X rays | Parathyroid hormone | Correlation analysis | Orthopedics | Healing | Bone | Laboratory animals | Index Medicus
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 03/2019, Volume 20, Issue 6, p. 1513
The excellent publication by Häusler and Weber [...]. 
Index Medicus | hypercalcemia | vitamin D supplementation | multiple sclerosis | IL-6 | serum neurofilament light chain
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2010, Volume 55, Issue 5, pp. 773 - 799
This commentary provides a US perspective on the 2009 KDIGO (Kidney Disease: Improving Global Outcomes) Clinical Practice Guideline for the Diagnosis,... 
Nephrology | chronic kidney disease | Kidney Disease: Improving Global Outcomes (KDIGO) | Kidney Disease Outcomes Quality Initiative (KDOQI) | Clinical practice guideline | guideline adaptation | renal osteodystrophy | mineral and bone disease | VITAMIN-D | MAINTENANCE HEMODIALYSIS-PATIENTS | X PHOSPHATE PRODUCT | IMPROVING GLOBAL OUTCOMES | ESRD PAYMENT PERSPECTIVES | PROPOSED RULE | DIALYSATE CALCIUM-CONCENTRATION | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | CHRONIC KIDNEY-DISEASE | STAGE RENAL-DISEASE | Monitoring, Physiologic - standards | United States | Humans | Hypercalcemia - therapy | Medicare - economics | Renal Dialysis - economics | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - therapy | Reimbursement Mechanisms | Chronic Kidney Disease-Mineral and Bone Disorder - etiology | Hyperphosphatemia - therapy | Renal Insufficiency, Chronic - economics | Bone Diseases, Metabolic - therapy | Phosphate-Binding Proteins - administration & dosage | Renal Insufficiency, Chronic - classification | Chronic Kidney Disease-Mineral and Bone Disorder - therapy | Global Health | Bone Diseases, Metabolic - prevention & control | Bone Diseases, Metabolic - diagnosis | Bone Diseases, Metabolic - etiology | Chronic Kidney Disease-Mineral and Bone Disorder - diagnosis | Calcinosis | Hyperphosphatemia - etiology | Hypercalcemia - etiology | Practice Guidelines as Topic | Index Medicus
Journal Article